Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Evommune, Inc.

EVMN · NYSE · CIK 0002044725 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

2 qualifying P purchase groups
in the current 180-day scoring window

18 Form 4 transaction lines observed in the same window
9 sales · 7 option, withholding, award, gift or other lines

Last qualifying purchase2026-07-08 · Carver Kyle · $13.3K

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying2 qualifying line group(s)
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION91%Largest buyer: KIRSCH ARTHUR S · $133.0K
CLUSTER BUYING · 15D2 insidersPeak activity: 2026-07-07–2026-07-08

Roles in the peak window: Chief Financial Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Patel Jeegar PravinkumarChief Scientific Officer
○▼○▼
Pena Luis C.President & CEO
▼▼○
Carver KyleChief Financial Officer
○▼●
Drew Janice SuzannChief of Dev. Operations
○▼
Moss Gregory S.Chief Business & Legal Officer
○▼
Cohen David EDirector
▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-07-08 · Carver Kyle.

Recent Form 4 activity

7Purchases
9Sales
34Other Form 4 lines
33SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING9 sale line(s) · context only
OTHER7 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,892,407
Previous report
2,876,209
Avg daily volume
749,525
Days to cover
3.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-08Carver KylePurchase (P)Common Stock1,000USD 13.26USD 13,260SEC filing ↗
2026-07-07KIRSCH ARTHUR SPurchase (P)Common Stock10,000USD 13.30USD 133,000SEC filing ↗
2025-12-19Hopfner Robert LornePurchase (P)Common Stock1,000USD 17.35USD 17,350SEC filing ↗
2025-11-07Verduyn-van Weegen Felice IsabelPurchase (P)Common Stock1,562,500USD 16.00USD 25,000,000SEC filing ↗
2025-11-07RA CAPITAL MANAGEMENT, L.P.Purchase (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC filing ↗
2025-11-07LSP 7 Cooperative UAPurchase (P)Common Stock1,562,500USD 16.00USD 25,000,000SEC filing ↗

Form 4 evidence

50 transaction lines in the latest 365-day window; 50 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Pena Luis C.Award / grant (A)Common Stock1,115USD 7.02USD 7,827SEC filing ↗
2026-07-08Carver KylePurchase (P)Common Stock1,000USD 13.26USD 13,260SEC filing ↗
2026-07-07KIRSCH ARTHUR SPurchase (P)Common Stock10,000USD 13.30USD 133,000SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-30Pena Luis C.Award / grant (A)Common Stock1,115USD 7.02USD 7,827SEC filing ↗
2026-07-08Carver KylePurchase (P)Common Stock1,000USD 13.26USD 13,260SEC filing ↗
2026-07-07KIRSCH ARTHUR SPurchase (P)Common Stock10,000USD 13.30USD 133,000SEC filing ↗
2026-06-22Pena Luis C.Sale (S)Common Stock7,438USD 22.71USD 168,917SEC filing ↗
2026-06-22Patel Jeegar PravinkumarSale (S)Common Stock1,488USD 22.50USD 33,480SEC filing ↗
2026-06-22Patel Jeegar PravinkumarOption exercise / conversion (M)Common Stock1,488USD 3.84USD 5,714SEC filing ↗
2026-06-22Drew Janice SuzannSale (S)Common Stock20,000USD 22.63USD 452,600SEC filing ↗
2026-06-22Drew Janice SuzannOption exercise / conversion (M)Common Stock20,000USD 3.15USD 63,063SEC filing ↗
2026-06-02Cohen David ESale (S)Common Stock6,056USD 20.33USD 123,094SEC filing ↗
2026-06-01Pena Luis C.Sale (S)Common Stock16,787USD 22.74USD 381,736SEC filing ↗
2026-06-01Patel Jeegar PravinkumarSale (S)Common Stock16,687USD 22.74USD 379,462SEC filing ↗
2026-06-01Patel Jeegar PravinkumarOption exercise / conversion (M)Common Stock13,512USD 3.84USD 51,886SEC filing ↗
2026-05-28Moss Gregory S.Sale (S)Common Stock14,223USD 22.83USD 324,711SEC filing ↗
2026-05-28Moss Gregory S.Option exercise / conversion (M)Common Stock14,223USD 1.71USD 24,321SEC filing ↗
2026-05-28Carver KyleSale (S)Common Stock18,175USD 22.84USD 415,117SEC filing ↗
2026-05-28Carver KyleOption exercise / conversion (M)Common Stock15,000USD 2.99USD 44,850SEC filing ↗
2026-02-17LSP 7 Cooperative UAAward / grant (A)Common Stock358,680USD 27.88USD 9,999,998SEC filing ↗
2026-02-17Verduyn-van Weegen Felice IsabelAward / grant (A)Common Stock358,680USD 27.88USD 9,999,998SEC filing ↗
2026-02-17Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.Award / grant (A)Common Stock35,868USD 27.88USD 1,000,000SEC filing ↗
2025-12-19Hopfner Robert LornePurchase (P)Common Stock1,000USD 17.35USD 17,350SEC filing ↗
2025-12-09Pena Luis C.Tax withholding (F)Common Stock28,138USD 17.84USD 501,982SEC filing ↗
2025-12-09Patel Jeegar PravinkumarTax withholding (F)Common Stock7,513USD 17.84USD 134,032SEC filing ↗
2025-12-09Moss Gregory S.Tax withholding (F)Common Stock13,624USD 17.84USD 243,052SEC filing ↗
2025-12-09Drew Janice SuzannTax withholding (F)Common Stock5,074USD 17.84USD 90,520SEC filing ↗
2025-12-09Carver KyleTax withholding (F)Common Stock13,290USD 17.84USD 237,094SEC filing ↗
2025-12-09Bauer EugeneTax withholding (F)Common Stock1,478USD 17.84USD 26,368SEC filing ↗
2025-11-07Verduyn-van Weegen Felice IsabelPurchase (P)Common Stock1,562,500USD 16.00USD 25,000,000SEC filing ↗
2025-11-07Verduyn-van Weegen Felice IsabelC (C)Common Stock3,367,133USD —USD —SEC filing ↗
2025-11-07RA CAPITAL MANAGEMENT, L.P.Purchase (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC filing ↗
2025-11-07RA CAPITAL MANAGEMENT, L.P.C (C)Common Stock2,208,770USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerEVMN
CIK0002044725
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history50 transaction lines from 2025-11-07 to 2026-09-30
7 P purchase lines · 9 S sale lines · 34 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.